Speed is tricky for the next phase, which is to see if it (1) actually affects progress of the disease and (2) is well tolerated long-term. But may it all go s

Speed is tricky for the next phase, which is to see if it (1) actually affects progress of the disease and (2) is well tolerated long-term. But may it all go smoothly! ISTR there are statistical techniques which can help, but even so, we're on for a 2-year trial in all likelihood. My neurologist was literally dancing in his chair. :) It'll be interesting to see if the technique extends to other single-cause conditions.